Denise M. Sloan, PhD
Professor, Psychiatry

Biography
Denise M. Sloan, Ph.D. is a psychologist and Associate Director in the Behavioral Science Division, National Center for PTSD. She is also a Professor of Psychiatry at Chobanian and Avedisian School of Medicine.
Her research expertise is in psychosocial treatments for PTSD and emotion in psychopathology. She has received funding from her work from several organizations, including the National Institute for Mental Health and Department of Veterans Affairs. Dr. Sloan is a member of several editorial boards including Behavior Therapy, Behaviour Research and Therapy, and Journal of Abnormal Psychology.
Other Positions
- VA Boston Healthcare System
Education
- Case Western Reserve University, PhD
- Case Western Reserve University, MA
- Stony Brook University, BA
Publications
- Published on 12/12/2024
Shayani DR, Alpert E, Barnes JB, Sloan DM, Hayes AM. Identifying predictors of long-term treatment outcomes using narratives from written exposure therapy and cognitive processing therapy for PTSD. Psychol Trauma. 2024 Dec 12. PMID: 39666474.
Read at: PubMed - Published on 12/12/2024
Marx BP, Sloan DM, Keane TM, Pollack S, Schnurr PP. Veterans health administration leads the way in population mental health science: Commentary on Dodge et al. (2024). Am Psychol. 2024 Dec 12. PMID: 39666494.
Read at: PubMed - Published on 5/26/2024
Comer JS, Georgiadis C, Schmarder K, Chen D, Coyne CA, GudiƱo OG, Kazantzis N, Langer DA, LeBeau RT, Liu RT, McLean C, Sloan DM, Williams MT, Pachankis JE. Reckoning With Our Past and Righting Our Future: Report From the Behavior Therapy Task Force on Sexual Orientation and Gender Identity/Expression Change Efforts (SOGIECEs). Behav Ther. 2024 Jul; 55(4):649-679. PMID: 38937042.
Read at: PubMed - Published on 3/2/2024
Pless Kaiser A, Daks JS, Korsun L, Heintz H, Moye J, Sloan DM, Cook JM, Vogt D, Spiro A. Enhancing social functioning in older veterans with PTSD: Rationale and design of an intervention and initial RCT. Contemp Clin Trials. 2024 Apr; 139:107485. PMID: 38432471.
Read at: PubMed - Published on 2/29/2024
Sloan DM, Marx BP. State of the Science: Written Exposure Therapy for the Treatment of Posttraumatic Stress Disorder. Behav Ther. 2024 Nov; 55(6):1222-1232. PMID: 39443063.
Read at: PubMed - Published on 2/15/2024
DeJesus CR, Trendel SL, Sloan DM. A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms. Psychol Trauma. 2024 Feb 15. PMID: 38358724.
Read at: PubMed - Published on 2/13/2024
Sloan DM. Editorial: State of the Journal. J Trauma Stress. 2024 Apr; 37(2):203-204. PMID: 38351369.
Read at: PubMed - Published on 1/9/2024
Meredith LS, Wong EC, Marx BP, Han B, Korn AR, Tobin JN, Cassells A, Williamson S, Franco M, Overa CC, Holder T, Lin TJ, Sloan DM. Design of a hybrid implementation effectiveness cluster randomized controlled trial of delivering written exposure therapy for PTSD in underserved primary care settings. Contemp Clin Trials. 2024 Mar; 138:107435. PMID: 38211725.
Read at: PubMed - Published on 11/14/2023
Lee DJ, Crowe ML, Weathers FW, Bovin MJ, Ellickson S, Sloan DM, Schnurr P, Keane TM, Marx BP. An Item Response Theory Analysis of the Clinician-Administered PTSD Scale for DSM-5 Among Veterans. Assessment. 2024 Sep; 31(6):1262-1269. PMID: 37960836.
Read at: PubMed - Published on 11/11/2023
Stoycos SA, Straud CL, Stanley IH, Marx BP, Resick PA, Young-McCaughan S, Peterson AL, Sloan DM. Benchmarking secondary outcomes to posttraumatic stress disorder symptom change in response to cognitive processing and written exposure therapy for posttraumatic stress disorder. J Anxiety Disord. 2023 Dec; 100:102794. PMID: 37980801.
Read at: PubMed
View 130 more publications: View full profile at BUMC